Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Harrow Health Q4 Adj EPS $(0.20) Misses $(0.04) Estimate, Sales $36.35M Miss $37.86M Estimate

Author: Benzinga Newsdesk | March 19, 2024 05:51pm

Harrow Health (NASDAQ:HROW) reported quarterly Adj losses of $(0.20) per share which missed the analyst consensus estimate of $(0.04) by 400 percent. This is a 385.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $36.35 million which missed the analyst consensus estimate of $37.86 million by 3.98 percent. This is a 78.83 percent increase over sales of $20.33 million the same period last year.

Posted In: HROW


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist